<?xml version="1.0" encoding="UTF-8"?>
<akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <act name="CPL">
    <meta>
      <identification source="#ny-legislature">
        <FRBRWork>
          <FRBRthis value="/akn/us-ny/act/cpl/section-60.49"/>
          <FRBRuri value="/akn/us-ny/act/cpl/section-60.49"/>
          <FRBRdate date="2021-12-10" name="enacted"/>
          <FRBRauthor href="#ny-legislature"/>
          <FRBRcountry value="us-ny"/>
          <FRBRnumber value="60.49"/>
          <FRBRname value="CPL"/>
        </FRBRWork>
        <FRBRExpression>
          <FRBRthis value="/akn/us-ny/act/cpl/section-60.49/eng@2025-12-31"/>
          <FRBRuri value="/akn/us-ny/act/cpl/section-60.49/eng@2025-12-31"/>
          <FRBRdate date="2025-12-31" name="publication"/>
          <FRBRauthor href="#arch"/>
          <FRBRlanguage language="eng"/>
        </FRBRExpression>
        <FRBRManifestation>
          <FRBRthis value="/akn/us-ny/act/cpl/section-60.49/eng@2025-12-31/main.xml"/>
          <FRBRuri value="/akn/us-ny/act/cpl/section-60.49/eng@2025-12-31/main.xml"/>
          <FRBRdate date="2025-12-31" name="generation"/>
          <FRBRauthor href="#arch"/>
        </FRBRManifestation>
      </identification>
      <references source="#arch">
        <TLCOrganization eId="arch" href="https://cosilico.ai" showAs="Cosilico Arch"/>
        <TLCOrganization eId="ny-legislature" href="https://legislation.nysenate.gov" showAs="New York State Legislature"/>
      </references>
    </meta>
    <body>
      <section eId="sec_60_49">
        <num>60.49</num>
        <heading>Possession of opioid antagonists; receipt into evidence</heading>
        <content>
          <p>ยง 60.49 Possession of opioid antagonists; receipt into evidence.\n  1. Evidence that a person was in possession of an opioid antagonist\nmay not be admitted at any trial, hearing or other proceeding in a\nprosecution for any offense under sections 220.03, 220.06, 220.09,\n220.16, 220.18, or 220.21 of the penal law for the purpose of\nestablishing probable cause for an arrest or proving any person's\ncommission of such offense.\n  2. For the purposes of this section, opioid antagonist is defined as a\ndrug approved by the Food and Drug Administration that, when\nadministered, negates or neutralizes in whole or in part the\npharmacological effects of an opioid in the body and shall be limited to\nnaloxone and other medications approved by the department of health for\nsuch purpose.\n</p>
        </content>
      </section>
    </body>
  </act>
</akomaNtoso>